A novel study to examine the association of PCSK9 rs505151 polymorphism and coronary artery disease in north Indian population
- 49 Downloads
There is a drastic increase in the number of people suffering from coronary artery disease (CAD) worldwide with Indians being no exception. Being a developing country and experiencing a dramatic shift in lifestyle and eating habits, urbanization and industrialization, all these factors have collectively predisposed the Indian population towards CAD and the prevalence data are quite alarming. Genetic studies have disclosed the role of genes in CAD susceptibility and severity. One such gene is proprotein convertase subtilisin/kexin type 9 (PCSK9) which is sought to modulate the cholesterol levels and hence, has implications in CAD. We aim to explore the association of PCSK9 A/G (rs505151) polymorphism and hence, the susceptibility towards CAD in the north Indian population. Five-hundred angiographically confirmed CAD patients and 500 healthy individuals as control were genotyped by polymerase chain reaction-restriction fragment length polymorphism. Statistical analysis revealed a significant association with the G allele with odds ratio (OR)=1.50, 95% confidence interval (CI)=1.22–1.85 and P=0.000. Also, a strong association was observed for CAD risk with OR=1.590, 95% CI=1.106–2.284 and P=0.012. However, the homozygous GG mutant genotype was found to be completely absent from our population. Analysis of the dominant model also revealed an association with CAD risk. Our work demonstrated for the first time the association of PCSK9 A/G (rs505151) polymorphism with CAD risk in the north Indian population.
Keywordgenetic polymorphism north Indian population coronary artery disease polymerase chain reaction-restriction fragment length polymorphism low density lipoprotein receptor
All the authors are grateful to the participants (control subjects and patients involved in this study.
- Chen S. N., Ballantyne C. M., Gotto Jr A. M., Tan Y., Willerson J. T. and Marian A. J. 2005 A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J. Am. Coll. Cardiol. 45, 1611–1619.CrossRefGoogle Scholar
- Huang C. C., Fornage M., Lloyld-Jones D. M., Wei G. S., Boerwinkle E. and Liu K. 2009 Longitudinal association of PCSK9 sequence variations with LDL-cholesterol levels: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ. Cardiovasc. Genet. 108, 828467.Google Scholar
- LeBlanc M., Zuber V., Andreassen B. K., Witoelar A., Zeng L., Bettella F. et al. 2015 Identifying novel gene variants in coronary artery disease and shared genes with several cardiovascular risk factors. Circ. Res. 115, 306629.Google Scholar
- Maiti S., Biswas P., Banerjee S., Jana N. K. 2017 Study of the association of PCSK9/Eam1104I gene polymorphism with plasma lipid concentration and CAD in West Bengal population. Int. J. Life Sci. Sci. Res. 3, 1271–1277.Google Scholar
- Meng Y. and Liu Z. 2011 A study on the correlation between E670G polymorphism of PCSK9 gene and coronary artery disease in the Guangdong population. J. Trop. Med. 11, 137–140.Google Scholar
- Mo Y., Li W., Zhong Y. and Zhang X. 2015 Dongguan Han patients with coronary artery PCSK9 gene SNP and its prognosis. Int. J. Lab. Med. 12, 1725–1727.Google Scholar
- Polisecki E., Peter I., Robertson M., McMahon A. D., Ford I., Packard C. et al. 2008 Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population. Atherosclerosis 200, 95–101.CrossRefGoogle Scholar
- Tveten K., Holla Ø. L., Cameron J., Strøm T. B., Berge K. E., Laerdahl J. K. et al. 2011 Interaction between the ligand-binding domain of the LDL receptor and the C-terminal domain of PCSK9 is required for PCSK9 to remain bound to the LDL receptor during endosomal acidification. Hum. Mol. Genet. 21, 1402–1409.CrossRefGoogle Scholar